Synchron - About the company
Synchron is a series D company based in Brooklyn (United States), founded in 2016 by Rahul Sharma. It operates as a Developer of implantable bioelectronics for the treatment of neurological conditions. Synchron has raised $345M in funding from investors like Khosla Ventures, Arch Venture Partners and Double Point Ventures, with a current valuation of $*****. The company has 83 active competitors, including 28 funded and 7 that have exited. Its top competitors include companies like ElectroCore, Neuralink and ONWARD.
Company Details
Developer of implantable bioelectronics for the treatment of neurological conditions. The company offers a motor neuroprosthesis the Stentrode which helps paralyzed patients regain the ability to communicate. Also, provides endovascular neuromodulation minimally invasive device that stimulates brain or nerve activity for the treatment of Parkinson’s disease, epilepsy, depression, and others.
- Website
- synchron.com
- Email ID
- *****@synchron.com, *****@synchron.com
- Registered Address
- Brooklyn, NY
Key Metrics
Founded Year
2016
Location
Brooklyn, United States
Stage
Series D
Total Funding
$345M in 6 rounds
Latest Funding Round
Post Money Valuation
$***** as on Jan 01, 2026
Investors
Ranked
3rd among 83 active competitors
Employee Count
130 as on Sep 30, 2026
Investment & Acquisitions
Similar Companies
Legal entities associated with Synchron
Synchron is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
SYNCHRON, INC. CIN: 6770084 , United States, Active | Jun 23, 2022 | - | - | - |
Synchron, Inc CIN: 20-5231690 , United States, Active | Dec 31, 2015 | - | 53 (As on Dec 31, 2020) | - |
Sign up to download Synchron's company profile
Synchron's funding and investors
Synchron has raised a total funding of $345M over 6 rounds. Its first funding round was on Apr 04, 2017. Its latest funding round was a Series D round on Nov 06, 2025 for $*****. 12 investors participated in its latest round. Synchron has 33 institutional investors and 2 angel investors.
Here is the list of recent funding rounds of Synchron:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 06, 2025 | 6779920 | Series D | 2769768 | 4791159 | 1315282 | 7107937 |
Dec 15, 2022 | 7944685 | Series C | 6786255 | 2622898 | 4633346 | |
Dec 26, 2021 | 8487551 | Grant (prize money) | 1288621 | 5250478 | 4671755 |
View details of Synchron's funding rounds and investors
Synchron's founders and board of directors
Founder? Claim ProfileThe founders of Synchron is Rahul Sharma. Thomas Oxley is the CEO of Synchron.
Here are the details of Synchron's key team members:
- Rahul Sharma: Co-Founder of Synchron.
View details of Synchron's Founder profiles and Board Members
Synchron's employee count trend
Synchron has 130 employees as of Sep 26. Here is Synchron's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Synchron's Competitors and alternates
Top competitors of Synchron include ElectroCore, Neuralink and ONWARD. Here is the list of Top 10 competitors of Synchron, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | ElectroCore 2005, Basking Ridge (United States), Public | Developer of non-invasive vagus nerve stimulation devices | $161M | 69/100 | |
2nd | Neuralink 2016, Fremont (United States), Series E | Provider of implantable brain-computer interfaces | $1.29B | 66/100 | |
3rd | Synchron 2016, Brooklyn (United States), Series D | Developer of implantable bioelectronics for the treatment of neurological conditions | $345M | 64/100 | |
4th | ONWARD 2014, Eindhoven (Netherlands), Public | Developer of a therapeutic device for spinal cord injuries | $35M | 61/100 | |
5th | Nalu Medical 2014, Carlsbad (United States), Acquired | Developer of a neurostimulation system for managing intractable chronic pain | $231M | 61/100 | |
6th | Paradromics 2015, Austin (United States), Series A | Provider of data streaming brain-computer interfaces | $88.7M | 59/100 | |
7th | Manufacturer of active implantable neurotechnology devices, components, and sub-assemblies | $21.6M | 57/100 | ||
8th | Neurovalens 2013, Belfast (United Kingdom), Series A | Developer of non-invasive neurostimulation products | $26.1M | 57/100 | |
9th | BlueWind Medical 2010, Herzliya (Israel), Series B | Developer of neurostimulation device for the treatment of overactive bladder | $112M | 54/100 | |
10th | SpineX 2018, Los Angeles (United States), Seed | Developer of a medical device for neurological conditions | - | 53/100 |
Looking for more details on Synchron's competitors? Click here to see the top ones
Synchron's Investments and acquisitions
Synchron has a total of 1 investment in ACQUANDAS. Synchron has not made any acquisitions as of now.Reports related to Synchron
Here is the latest report on Synchron's sector:
News related to Synchron
Media has covered Synchron for a total of 5 events in the last 1 year, 1 of them has been about company updates.
•
•
•
•
Lumonus Secures A$25 Million in Series B to Expand AI Oncology Workflows GloballyPR Newswire•Nov 07, 2025•Aviron, Oncology Ventures, Luminous Wheels, Lumonus and 6 others
•
Synchron Raises $200 Million Series D to Advance Brain-Computer Interface TechnologyBusiness Wire•Nov 06, 2025•Synchron, National Reconstruction Fund, Double Point Ventures, T.Rx Capital and 9 others
•
Synchron Debuts Thought-Controlled iPad Experience with Apple's BCI ProtocolBusiness Wire•Aug 04, 2025•Synchron
•
•
•
Synchron Unveils Chiral™, the World’s First Cognitive AI Brain Foundation ModelBusiness Wire•Mar 19, 2025•Synchron
•
Synchron to Advance Implantable Brain-Computer Interface Technology with NVIDIA HoloscanBusiness Wire•Jan 14, 2025•Synchron, Nvidia
Are you a Founder ?
FAQs about Synchron
Explore our recently published companies
- kassandra - Spain based, Unfunded company
- Tasigns - Los Angeles based, Unfunded company
- Wizwealth.com - 2009 founded, Unfunded company
- Duco Speciality Coatngs - South Africa based, 1980 founded, Unfunded company
- Desk Stand - Cape Town based, 2015 founded, Unfunded company
- Folkfilter - Sweden based, 1994 founded, Unfunded company
